$PBI

PITNEY BOWES INC /DE/ (PBI): Results of Operations and Financial Condition

PITNEY BOWES INC /DE/ (PBI) filed an SEC Form 8-K — Results of Operations and Financial Condition. pbi-20260729 0000078814 false 0000078814 2026-07-29 2026-07-29 0000078814 us-gaap:CommonStockMember 2026-07-29 2026-07-29 0000078814 pbi:A6.70Notesdue2043Member 2026-07-29 2026-07-29 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K Current Report P

Original reporting
Published Jul 29, 2026, 8:09 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 8:10 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$PBI
Neutral
low confidence
Mentioned
$PBI
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$PBINeutralMed
01

Why it matters

Because the exhibits are incorporated by reference, the market impact depends on whether the attached materials include earnings surprises, balance-sheet/cash-flow changes, and any updated forward-looking statements or outlook.

02

Market read

This is a new, primary-source disclosure of Q2 2026 financial results that can drive near-term trading once the exhibits’ figures and any outlook changes are reviewed.

03

What to watch

Traders should focus on any changes in adjusted results, cash flow, customer loss or contract churn, and any updated cost-savings or capital allocation language that may be in Exhibit 99.1/99.2, which are not included in the scrape.

Relevance 7/10Novelty 5/10Timing: after-hours SEC filing on July 29, 2026 with Q2 2026 results exhibits

Background

The filing is an SEC Form 8-K, Item 2.02, stating Pitney Bowes issued a press release and a CEO letter covering consolidated financial results for the three and six months ended June 30, 2026.

Company-level read

Ticker impact

$PBINeutralLow confidence
Context

Pitney Bowes filed an 8-K with its Q2 2026 results and attached a CEO letter, making the company’s financial update the primary disclosure.

Expected impact

Moderate two-sided move possible on open as traders digest the attached Q2 results and any updated outlook in the exhibits.

Evidence & confidence

The provided text confirms the filing and attachments but does not include the actual financial figures, guidance, or key deltas, so the direction and magnitude cannot be inferred from the scrape alone.

Market effects

Updates from a major postal and shipping services provider can affect read-across sentiment for mail-volume and logistics-adjacent demand, but the scrape lacks the actual numbers.

Primarily US-focused given NYSE listing and US postal/shipping regulatory risk disclosures.

Limited from the provided text; the filing references broader market risks but provides no new global datapoints.

Counterpoint

If the exhibits largely reiterate previously guided trends or contain only modest variance, the market reaction may fade quickly and the filing becomes more of a routine recap than a catalyst.

Key entities

  • Pitney Bowes Inc.

    Subject of the 8-K, reporting Q2 2026 results via attached press release and CEO letter.

  • Kurt Wolf

    President and CEO who issued a letter regarding the company’s financial results for the three months ended June 30, 2026.

Related articles

$PBIMedAI 8/10

Pitney Bowes (PBI) Q2 2026 Earnings Call Transcript

Pitney Bowes (PBI) reported Q2 2026 revenue of $451 million, down 2%, with adjusted EBIT of $116 million up 13% and adjusted free cash flow of $148 million up 39%. Management raised guidance for adjusted EBIT to $445-$475 million and adjusted EPS to $1.55-$1.70, citing cost actions and a $5 million tariff refund, while Presort faced lower volumes and higher fuel costs.

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

$JOBYMedAI 8/10

Joby Aviation Q2 Earnings Call Highlights

Joby Aviation (NYSE:JOBY) raised full-year revenue guidance to $115 million to $125 million from $105 million to $115 million. Q2 cash use was about $202 million and GAAP net loss was $245 million, including a $108 million non-cash warrant and earn-out fair value change. For 2H 2026, it expects $385 million to $415 million cash use. The company said aircraft availability is a key constraint on Blade routes and outlined manufacturing, infrastructure, and JV plans with Toyota.

$JHXMedAI 8/10

James Hardie Industries Q1 Earnings Call Highlights

James Hardie (NYSE:JHX) said about one-third of fiber-cement growth came from strategic initiatives, one-third from prior-year destocking comparisons, and the rest from price and mix. June sell-through rose 19%. Deck, Rail & Accessories sales fell 5% to $305.1M with 27.1% Adjusted EBITDA margin. Q2 net sales forecast $1.485B-$1.575B and FY2027 outlook raised; FCF Q1 was $254M and it redeemed $400M notes.

$IXMed

Orix Corp Ads Q1 Earnings Call Highlights

ORIX (NYSE: IX) discussed Q1 results and outlook on an earnings call, including potential Q3 Kioxia sale and valuation losses tied to Kioxia’s end-September share price. ORIX shifted its dividend basis to adjusted profits, targeting an interim dividend of JPY 107.27 per share and full-year JPY 187.36. It reported JPY 115.7B capital gains and about JPY 300B capital-recycling inflows, and continued a JPY 250B buyback.